Related Experiment Video
Updated: Jul 4, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
Published on: September 10, 2016
Probiotics for children with diarrhea: an update
1Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, IL 60637, USA. sguandalini@peds.bsd.uchicago.edu
Insights
Probiotics show modest efficacy for preventing diarrhea in day-care centers but offer clear benefits for antibiotic-associated diarrhea and treating infectious diarrhea in children. Lactobacillus GG and Saccharomyces boulardii are the most effective strains.
Area of Science:
- Pediatrics
- Microbiology
- Gastroenterology
Background:
- Diarrhea is a common childhood illness with various causes and settings.
- Probiotics are live microorganisms intended to provide health benefits when consumed.
- The efficacy of probiotics for pediatric diarrhea requires comprehensive evaluation across different scenarios.
Purpose of the Study:
- To review the evidence on probiotic efficacy for pediatric diarrhea in diverse clinical settings.
- To identify the most effective probiotic strains and optimal dosages for different types of diarrhea.
- To assess the clinical significance of probiotics in preventing and treating childhood diarrhea.
Main Methods:
- Systematic review of randomized, placebo-controlled trials.
- Analysis of studies focusing on probiotics for day-care-acquired, hospital-acquired, antibiotic-associated, and infectious diarrhea.
- Evaluation of specific probiotic strains including Lactobacillus GG, Bifidobacterium spp., and Saccharomyces boulardii.
Main Results:
- Modest evidence for preventing day-care-acquired diarrhea; efficacy is strain-dependent and clinically mild.
- Conflicting results regarding the prevention of hospital-acquired diarrhea.
- Clear evidence supports the efficacy of Lactobacillus GG and Saccharomyces boulardii in preventing antibiotic-associated diarrhea.
- Significant, moderate clinical benefit observed for Lactobacillus GG, Saccharomyces boulardii, and L. reuteri in treating acute infectious diarrhea, reducing duration by over one day, primarily for rotavirus infections.
Conclusions:
- Probiotics, particularly Lactobacillus GG and Saccharomyces boulardii, are effective for preventing antibiotic-associated diarrhea and treating acute infectious diarrhea in children.
- Strain and dose dependency (≥10 billion/day) are critical factors for probiotic efficacy.
- Evidence for preventing diarrhea in day-care centers and hospitals is less robust, requiring further investigation.
Abstract:
This review focuses on the efficacy of probiotics for diarrhea in children in different settings: day-care centers, diarrhea acquired in the hospital, antibiotic-associated diarrhea, and treatment of acute infectious diarrhea. For prevention of diarrhea acquired in day-care centers, 5 randomized and placebo-controlled trials have been published. Probiotics tested were Lactobacillus GG, Bifidobacterium lactis (alone or in combination with Streptococcus thermophilus), and Lactobacillus reuteri. The evidence of their efficacy in these settings is only modest: statistically significant for some strains only and in any case of minimal to mild clinical importance. Few trials have examined the potential role of probiotics in preventing the spread of diarrhea in hospitalized children, an event most commonly due to either rotavirus or Clostridium difficile, and they have yielded conflicting results. Overall, these studies provide only weak evidence on the efficacy of probiotics. On the other hand, a large number of trials on the role of probiotics in preventing the onset of antibiotic-associated diarrhea have been published. Most commonly employed probiotics were Lactobacillus GG, Bifidobacterium spp., Streptococcus spp., and the yeast Saccharomyces boulardii. In general, these trials do show clear evidence of efficacy, with the 2 most effective strains being Lactobacillus GG and S. boulardii. Today, we have a large number of published clinical trials on the role of probiotics in treating sporadic infectious diarrhea in children, and many of them are randomized, blinded, and controlled. They consistently show a statistically significant benefit and moderate clinical benefit of a few, well-identified probiotic strains-mostly Lactobacillus GG and S. boulardii, but also L. reuteri-in the treatment of acute watery diarrhea, primarily rotaviral, in infants and young children of developed countries. Such a beneficial effect seems to result in a reduction of diarrhea duration of little more than 1 day, and to be exerted mostly on diarrhea due to rotavirus. The effect is not only strain-dependent, but also dose-dependent, with doses of at least 10 billion/d being necessary.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Probiotics
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Microbiota Modulation by Antibiotics
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
